The p53 pathway in both cancer types is frequently inhibited, either by expression of human papillomavirus E6 oncogene, which induces p53 protein degradation in cervical carcinomas, or by mutation of the TP53 gene in breast carcinomas. The gene discussed is TP53; the disease is cancer.